Healthcare - Quarterly Revenue Analysis

Last updated 2024-12-21 04:06:25 (EST)

Quarterly Revenue Trend Analysis

Overall Quarterly Revenue Growth Trend of Healthcare Sector Companies.

Trend Chart of Adjusted Quarterly Revenue vs. Stock Price Trend Chart for Healthcare Sector ETF (XLV)

FindBillion.com

Seasonally Adjusted Quarterly Revenue Growth Rate


QoQ Growth Rate of Revenue	4.3%
YoY Growth Rate of Revenue	9.9%

Correlation Analysis between Quarterly Revenue and Stock Price

Determine the correlation between the stock price of the Healthcare Sector ETF (XLV) and the seasonally adjusted overall quarterly revenue of Healthcare sector companies. If there is a moderate to high correlation, the overall seasonally adjusted quarterly revenue can be used to estimate whether the stock price is reasonable.

Scatter Plot of Seasonally Adjusted Quarterly Revenue vs. Stock Price for Healthcare Sector

Seasonally Adjusted Quarterly Revenue and stock price of Healthcare Sector show a High Correlation. The higher the correlation, the greater the reference value.

The Coefficient of Determination
between Seasonally Adjusted Quarterly Revenue and Stock Price

High Correlation 0.94

FindBillion.com

Related Stocks

Related Healthcare sector stocks, along with their quarterly revenue growth rates (QoQ and YoY).

Ticker	Name	QoQ Growth Rate of Seasonally Adjusted Quarterly Revenue	YoY Growth Rate of Seasonally Adjusted Quarterly Revenue
RETA	Reata Pharmaceuticals, Inc.	11273.7%	2885%
BNTX	BioNTech SE	698.7%	39%
MRNA	Moderna, Inc.	510.5%	1.3%
MDGL	Madrigal Pharmaceuticals, Inc.	324.8%	轉虧為盈%
ITCI	Intra-Cellular Therapies, Inc.	96.1%	39.2%
IMGN	ImmunoGen, Inc.	68.1%	637.7%
PFE	Pfizer Inc.	32.7%	33.8%
HALO	Halozyme Therapeutics, Inc.	32.2%	34.3%
SRPT	Sarepta Therapeutics, Inc.	28.9%	40.8%
ASND	Ascendis Pharma A/S	28.4%	20.4%
GMAB	Genmab A/S	23.5%	16.8%
CYTK	Cytokinetics, Incorporated	22.4%	22.5%
MESO	Mesoblast Limited	22.2%	-14.4%
OSH	Oak Street Health, Inc.	19.8%	46.4%
MCK	McKesson Corporation	15.7%	21.3%
INCY	Incyte Corporation	13%	23.8%
WST	West Pharmaceutical Services, Inc.	11.6%	-0.1%
BMRN	BioMarin Pharmaceutical Inc.	10.3%	27.3%
CI	Cigna Corporation	10.2%	29.9%
SNN	Smith & Nephew plc	10.1%	8.7%
SNY	Sanofi	9.9%	11.5%
SWAV	ShockWave Medical, Inc.	8.5%	35.8%
RMD	ResMed Inc.	8.4%	27.2%
NVS	Novartis AG	8.1%	8.9%
REGN	Regeneron Pharmaceuticals, Inc.	8%	10.6%
CNC	Centene Corporation	7.9%	10.5%
RGEN	Repligen Corporation	7.7%	9.7%
STVN	Stevanato Group S.p.A.	6.7%	2.4%
NTRA	Natera, Inc.	6.5%	63.9%
MASI	Masimo Corporation	6.4%	5.4%
BDX	Becton, Dickinson and Company	6.3%	6.9%
BDXA	Becton, Dickinson and Company	6.3%	6.9%
BDXB	Becton, Dickinson and Company	6.3%	6.9%
MOH	Molina Healthcare, Inc.	6.2%	21%
EHC	Encompass Health Corporation	6.1%	11.9%
RVTY	Revvity, Inc.	6%	2%
WAT	Waters Corporation	5.7%	4%
CVS	CVS Health Corporation	5.4%	6.3%
HLN	Haleon plc	5.2%	0.8%
COR	Cencora	5.1%	14.7%
NVO	Novo Nordisk A/S	5.1%	21.4%
MDT	Medtronic plc	4.9%	5.2%
WBA	Walgreens Boots Alliance, Inc.	4.9%	6%
DOCS	Doximity, Inc.	4.6%	20.4%
DHR	Danaher Corporation	4.3%	-15.6%
BIIB	Biogen Inc.	4.2%	-2.5%
VRTX	Vertex Pharmaceuticals Incorporated	4.1%	11.6%
JAZZ	Jazz Pharmaceuticals plc	4%	8.5%
MMSI	Merit Medical Systems, Inc.	4%	7.8%
IQV	IQVIA Holdings Inc.	3.9%	4.3%
TEVA	Teva Pharmaceutical Industries Limited	3.9%	12.5%
UNH	UnitedHealth Group Incorporated	3.6%	10.3%
ANTM	Elevance Health Inc.	3.6%	5.4%
ELV	Elevance Health Inc.	3.6%	5.4%
UTHR	United Therapeutics Corporation	3.6%	22.9%
TFX	Teleflex Incorporated	3.4%	2.4%
ABC	AmerisourceBergen Corporation	3.3%	15%
UHS	Universal Health Services, Inc.	3.3%	11.2%
GILD	Gilead Sciences, Inc.	3.2%	7%
VEEV	Veeva Systems Inc.	2.9%	13.4%
ENSG	The Ensign Group, Inc.	2.9%	15%
TAK	Takeda Pharmaceutical Company Limited	2.6%	12.7%
BSX	Boston Scientific Corporation	2.4%	19.3%
A	Agilent Technologies, Inc.	2.4%	0.8%
BRKR	Bruker Corporation	2.4%	16.4%
ABT	Abbott Laboratories	2.2%	4.9%
AMGN	Amgen Inc.	2.2%	23.2%
QGEN	Qiagen N.V.	2.2%	5.5%
BIO	Bio-Rad Laboratories, Inc.	2%	2.8%
ATR	AptarGroup, Inc.	2%	1.8%
TMO	Thermo Fisher Scientific Inc.	1.9%	0.2%
LLY	Eli Lilly and Company	1.9%	20.4%
HUM	Humana Inc.	1.8%	11.3%
COO	The Cooper Companies, Inc.	1.8%	9.8%
JNJ	Johnson & Johnson	1.7%	5.2%
CHE	Chemed Corporation	1.7%	7.4%
SYK	Stryker Corporation	1.7%	11.9%
RPRX	Royalty Pharma plc	1.6%	5.3%
ISRG	Intuitive Surgical, Inc.	1.4%	16.9%
BMY	Bristol-Myers Squibb Company	1.3%	8.4%
IDXX	IDEXX Laboratories, Inc.	1.1%	6.6%
GEHC	GE HealthCare Technologies Inc.	1%	0.9%
DVA	DaVita Inc.	0.9%	4.6%
CRL	Charles River Laboratories International, Inc.	0.8%	-1.6%
TECH	Bio-Techne Corporation	0.6%	4.5%
EW	Edwards Lifesciences Corporation	0.5%	-8.5%
MEDP	Medpace Holdings, Inc.	0.4%	8.3%
SOLV	Solventum Corporation	0.4%	1.4%
AZN	AstraZeneca PLC	0.4%	18%
HQY	HealthEquity, Inc.	0.2%	20.5%
PKI	PerkinElmer, Inc.	-	-42.3%
FMS	Fresenius Medical Care AG & Co. KGaA	-0.1%	-3.6%
DGX	Quest Diagnostics Incorporated	-0.5%	8.4%
ZTS	Zoetis Inc.	-0.7%	11%
GKOS	Glaukos Corporation	-0.7%	23.9%
STE	STERIS plc	-0.9%	-1%
LH	Laboratory Corporation of America Holdings	-1.2%	7.4%
HCA	HCA Healthcare, Inc.	-1.2%	7.9%
BLCO	Bausch + Lomb Corporation	-1.3%	18.8%
GMED	Globus Medical, Inc.	-1.4%	63.1%
THC	Tenet Healthcare Corporation	-1.5%	1.1%
ABBV	AbbVie Inc.	-1.6%	3.8%
GRFS	Grifols, S.A.	-1.7%	7.8%
PEN	Penumbra, Inc.	-1.9%	11.1%
LNTH	Lantheus Holdings, Inc.	-2%	18.4%
MTD	Mettler-Toledo International Inc.	-2.1%	1.3%
MRK	Merck & Co., Inc.	-2.3%	4.4%
ABMD	Abiomed, Inc.	-2.5%	7.2%
EXAS	Exact Sciences Corporation	-3%	12.8%
PHG	Koninklijke Philips N.V.	-3.7%	-2.1%
RCM	R1 RCM Inc.	-4.1%	14.7%
ILMN	Illumina, Inc.	-4.1%	-3.5%
RDY	Dr. Reddy's Laboratories Limited	-4.3%	16.5%
DXCM	DexCom, Inc.	-4.5%	2%
VTRS	Viatris Inc.	-4.6%	-5.2%
ALC	Alcon Inc.	-4.8%	5.4%
HSIC	Henry Schein, Inc.	-5.1%	0.4%
CTLT	Catalent, Inc.	-6%	4.2%
HOLX	Hologic, Inc.	-6.8%	4.5%
ALGN	Align Technology, Inc.	-7.4%	1.8%
ZBH	Zimmer Biomet Holdings, Inc.	-8.6%	4%
GSK	GSK plc	-8.6%	-1.7%
INSP	Inspire Medical Systems, Inc.	-8.7%	32.5%
INSM	Insmed Incorporated	-9.6%	18.2%
BGNE	BeiGene, Ltd.	-9.7%	28.2%
ICLR	ICON Public Limited Company	-10.2%	-1.2%
SGEN	Seagen Inc.	-11%	27.1%
NBIX	Neurocrine Biosciences, Inc.	-11.5%	24.7%
CAH	Cardinal Health, Inc.	-12.6%	-4.5%
ELAN	Elanco Animal Health Incorporated	-12.7%	-3.6%
BPMC	Blueprint Medicines Corporation	-13.4%	126.6%
RXDX	Prometheus Biosciences, Inc.	-13.5%	-71.8%
EXEL	Exelixis, Inc.	-18.3%	14.3%
ALNY	Alnylam Pharmaceuticals, Inc.	-21.4%	-33.3%
SGFY	Signify Health, Inc.	-24.4%	11.9%
BAX	Baxter International Inc.	-27%	-27.2%
PODD	Insulet Corporation	-27.1%	-13.9%
LEGN	Legend Biotech Corporation	-28.5%	66.9%
ARGX	argenx SE	-29%	73.8%
IONS	Ionis Pharmaceuticals, Inc.	-41%	-6.9%
CERE	Cerevel Therapeutics Holdings, Inc.	-100%	-
KRTX	Karuna Therapeutics, Inc.	-	-100%
NUVL	Nuvalent, Inc.	-	-
PCVX	Vaxcyte, Inc.	-	-
RVMD	Revolution Medicines, Inc.	-	-
SMMT	Summit Therapeutics Inc.	-	-
ROIV	Roivant Sciences Ltd.	-	-

Disclaimer

1. The information provided is for reference only and does not constitute any guarantee of profits or specific stock and price point recommendations.

2. The information is not complete; for comprehensive data, please refer to the relevant websites.

3. All stock market data analyses are subject to survivorship bias.